Kala Pharmaceuticals Price to Book Ratio 2016-2021 | KALA

Historical price to book ratio values for Kala Pharmaceuticals (KALA) over the last 10 years. The current price to book ratio for Kala Pharmaceuticals as of October 26, 2021 is 1.38.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Kala Pharmaceuticals Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-27 1.75 1.35
2021-06-30 5.30 $1.30 4.07
2021-03-31 6.74 $1.72 3.92
2020-12-31 6.78 $1.70 3.99
2020-09-30 7.50 $1.89 3.97
2020-06-30 10.51 $2.31 4.55
2020-03-31 8.79 $2.59 3.39
2019-12-31 3.69 $0.82 4.48
2019-09-30 3.81 $1.25 3.05
2019-06-30 6.38 $1.80 3.54
2019-03-31 8.27 $2.43 3.40
2018-12-31 4.89 $3.10 1.58
2018-09-30 9.87 $2.23 4.43
2018-06-30 13.73 $2.77 4.96
2018-03-31 15.83 $3.27 4.84
2017-12-31 18.49 $3.65 5.06
2017-09-30 22.84 $4.06 5.62
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.117B $0.006B
Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology. The Company designs proprietary drug delivery technology to penetrate mucosal tissue such as the eyes, lungs, gastrointestinal tracts and the female reproductive systems. Kala Pharmaceuticals, Inc. is based in Waltham, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86